Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial

BACKGROUND: Tiotropium via the HandiHaler device is an established long-acting, anticholinergic bronchodilator that prevents exacerbations and improves lung function in patients with chronic obstructive pulmonary disease. We hypothesised that tiotropium would reduce pulmonary exacerbations and impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaram, Lata, Vandal, Alain C., Chang, Catherina L., Lewis, Chris, Tong, Cecilia, Tuffery, Christine, Bell, Jill, Fergusson, Wendy, Jeon, Gene, Milne, David, Jones, Stuart, Karalus, Noel, Hotu, Sandra, Wong, Conroy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178212/
https://www.ncbi.nlm.nih.gov/pubmed/34795034
http://dx.doi.org/10.1183/13993003.02184-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178212/
https://www.ncbi.nlm.nih.gov/pubmed/34795034
http://dx.doi.org/10.1183/13993003.02184-2021

Ejemplares similares